Zdrowie i gospodarka · 17/01/2007

FDA Denies RS Medical Corp.'s Petition to Reclassify Non-Invasive Bone Growth Stimulator

The FDA is seeking public comment on its decision to deny a petition to reclassify the non-invasive bone growth stimulator from class III to class II, following a recommendation from the Orthopaedic and Rehabilitation Devices Panel.